SureTrader SureTrader
Home > Boards > US OTC > Biotechs >

Mymetics Corporation (MYMX)

MYMX RSS Feed
Add MYMX Price Alert      Hide Sticky   Hide Intro
Moderator: HokieHead, corpus
Search This Board:
Last Post: 12/9/2016 3:52:54 PM - Followers: 28 - Board type: Free - Posts Today: 0

                    MyMetics                     

http://www.mymetics.com/

 

Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands. Focused on developing next generation preventative vaccines for infectious diseases. Mymetics core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins.

Mymetics currently has 5 vaccines in its pipeline:
HIV/AIDS
Intranasal Influenza
RSV
Herpes Simplex
Malaria

 


Current Share Structure:



Oustanding Shares: 303.7 million (11/2016 & no change since 2012)
Floating Shares: 76 million  (12/2016)

Current Market Cap (12/7/16): $5.0 million
Enterprise Value: $51.9 million*

*Enterprise value can be thought of as the theoretical takeover price if the company were to bought. In the event of such a buyout, an acquirer would generally have to take on the company's debt, but would pocket its cash for itself. EV differs significantly from simple market capitalization in several ways, and many consider it to be a more accurate representation of a firm's value.


RECENT NEWS WITH SANOFI:

Mymetics Starts Research Project with Sanofi for Influenza Vaccines

Dec 01, 2016
OTC Disclosure & News Service

EPALINGES, Switzerland, Dec. 1, 2016

EPALINGES, Switzerland, Dec. 1, 2016 /PRNewswire/ -- Mymetics Corporation (OTCQB: MYMX), a pioneer and leader in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases, announced today that its subsidiary Mymetics B.V. has agreed on a research project with Sanofi Pasteur, the vaccine division of Sanofi (NYSE: SNY). The project will investigate the immunogenicity of influenza vaccines based on Mymetics' proprietary virosome technology platform in pre-clinical settings. If this project is successful it could result in a further and more extensive collaboration between the two companies.

"We are very excited to start this initial collaboration project with Sanofi, a world leader in the vaccine industry," said Ronald Kempers, CEO of Mymetics. "We look forward to show that our proprietary virosome technology and more than 30 years of virosome vaccines expertise can make a valuable difference in improving the effectiveness and cost competitiveness of influenza vaccines."

About Mymetics
Mymetics Corp. (OTCQB: MYMX) is a Swiss based biotechnology company, with a Research Lab in the Netherlands, focused on the development of next-generation preventative vaccines for infectious diseases. It currently has five vaccines in its pipeline: HIV-1/AIDS, intra-nasal Influenza, Malaria, Chikungunya, Herpes Simplex Virus and the RSV vaccine. HIV, malaria and intra-nasal influenza vaccines have successfully finished Phase 1 clinical trials, while the others are in the pre-clinical phase.

Mymetics' core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Mymetics' vaccines are designed to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense, in combination with humoral and cellular immune responses as a second-line defense, which can be essential for the development of an effective vaccine.

Mymetics' unique approach is being validated through partnerships with leading pharmaceutical or research organizations, including projects with PATH-MVI and the Bill and Melinda Gates Foundation.

For further information, please visit www.mymetics.com.

 




 

OTC Disclosure & News Service

Release Date Title Type
Dec 1, 2016 Mymetics Starts Research Project with Sanofi for Influenza Vaccines Press Release
Sep 19, 2016 Mymetics and Texas Biomedical Research Institute Continue Collaboration on HIV Vaccine Development Press Release
Apr 11, 2016 Mymetics' HIV Vaccine Candidate Confirms Promise in Preclinical Study With the Texas Biomedical Research Institute Press Release
Apr 5, 2016 Mymetics Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate Press Release
Jan 28, 2016 Mymetics Announces Discontinuation of the RSV Collaborative Project Press Release
Apr 20, 2015 Mymetics' led consortium awarded Euro 8.4 million to develop thermo stable and cold chain independent vaccines Press Release
Jan 2, 2015 OTC Markets Group Welcomes Newly Verified OTCQB Companies – Jan. 2 Announcement
Nov 18, 2014 Mymetics Announces New Collaboration to Advance the Development of an Innovative Malaria Vaccine Candidate Press Release
Sep 29, 2014 Mymetics' Promising HIV Vaccine Candidate Obtains Funding to Begin Study at Texas Biomedical Research Institute Press Release

 





WEEKLY CHART:


  •  
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MYMX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
MYMX News: Current Report Filing (8-k) 12/01/2016 08:13:32 AM
MYMX News: Quarterly Report (10-q) 11/14/2016 02:43:10 PM
MYMX News: Quarterly Report (10-q) 08/12/2016 10:29:22 AM
PostSubject
#641  Sticky Note Mymetics Starts Research Project with Sanofi for Influenza Vaccines HokieHead 12/02/16 04:58:35 PM
#753   Finally some buying pressure on the ask EOD. DumpOnUrPump 12/09/16 03:52:54 PM
#752   <MYMX> HookieHead, I changed the float in the corpus 12/09/16 01:42:43 PM
#751   <MYMX> Yes. No changes made from the previous percentage. corpus 12/09/16 01:11:20 PM
#750   <MYMX> Shares seems tight. Hopefully in stronger hands now. corpus 12/09/16 01:05:41 PM
#749   MYMX ready for take-off... $MYMX pennyfinder 12/09/16 12:58:52 PM
#748   300M outstanding 25% of public float, which means pennyfinder 12/09/16 12:57:45 PM
#747   Sept.2015 >>> Start of exploratory study of two corpus 12/09/16 12:01:29 PM
#746   <<< Mymetics' Overview >>> ***UPDATED*** corpus 12/09/16 11:55:34 AM
#745   Perhaps...time will tell. retireat40 12/07/16 05:34:29 PM
#744   Congratulations! Good move there. corpus 12/07/16 05:11:05 PM
#743   Hello .. I'm buying a little to tuck MADDSTACKER 12/07/16 04:47:58 PM
#742   Exactly. This stock trading history says it all. corpus 12/07/16 04:06:56 PM
#741   PRE Loaded ... Lol no volume for last MADDSTACKER 12/07/16 03:58:33 PM
#740   Not surprise at all! You and I as corpus 12/07/16 03:30:02 PM
#739   CDEL seems to be front loading and be tyfoidhana 12/07/16 03:07:48 PM
#738   Certainly getting ugly for people who bought into retireat40 12/07/16 02:51:04 PM
#737   I may have to disagree. corpus 12/07/16 01:44:23 PM
#736   can not speak for the pump part Sanofi tyfoidhana 12/07/16 01:03:30 PM
#735   Top 2 smallcap vax stocks. remind2 12/07/16 12:46:21 PM
#734   Not unless it's an offshore hedge fund lol. retireat40 12/07/16 12:35:07 PM
#733   This is being shorted, easy to see. HokieHead 12/07/16 11:20:40 AM
#732   WOW! What was that? Someone wanted 300,000 and HokieHead 12/07/16 09:34:18 AM
#731   How Sanofi Identify partners? corpus 12/06/16 10:14:36 PM
#730   The right news to add to the sanofi Curt D 12/06/16 05:28:18 PM
#729   Hilarious how almost all the trades go off HokieHead 12/06/16 05:15:32 PM
#728   :-) Curt D 12/06/16 04:45:44 PM
#727   LOL! 'how far down the road the Icanslim 12/06/16 04:34:45 PM
#726   Lucky you. pennyfinder 12/06/16 02:31:26 PM
#725   SUCKS what one negative A-hole can do. KABOOM Soon!> KEEMAJO 12/06/16 01:30:01 PM
#724   Just added 20,000 at $0.018. Thanks.. HokieHead 12/06/16 12:29:58 PM
#723   I disagree with all your statements other than: HokieHead 12/06/16 12:22:50 PM
#722   I believe almost all of the trading is Harry Wickey 12/06/16 12:19:54 PM
#721   Unfortunately there are probably some that are hiding Curt D 12/06/16 11:21:09 AM
#720   Only 2 MMs left under $0.05.. HokieHead 12/06/16 11:17:06 AM
#719   All adding up to the fact that something Curt D 12/06/16 11:00:34 AM
#718   It's going to end up around 7-8 million HokieHead 12/06/16 10:58:29 AM
#717   Today's volume is going to easily surpass yesterday's volume. Curt D 12/06/16 10:54:28 AM
#716   The 8 DMA crossed above the 34 DMA Curt D 12/06/16 10:53:43 AM
#714   It's just a matter of time, look at HokieHead 12/06/16 10:48:38 AM
#712   Agreed. It seems .025 is where it always Curt D 12/06/16 10:45:30 AM
#711   Someone with a lot of shares is trying HokieHead 12/06/16 10:42:27 AM
#710   Yes, something is definitely in the works. It Curt D 12/06/16 10:36:40 AM
#709   I think Sanofi is involved in this volume HokieHead 12/06/16 10:35:16 AM
#708   Been moving nicely this morning with very good Curt D 12/06/16 10:33:53 AM
#707   Breakout time. Bust $0.025 and hold on above! HokieHead 12/06/16 10:23:20 AM
#706   Someone has been getting a ton of shares HokieHead 12/06/16 09:54:38 AM
#705   Who's selling almost a million @ 0.02? Unbelievable! corpus 12/06/16 09:51:52 AM
#704   Dollarland very attainable! corpus 12/06/16 09:34:43 AM
#703   That stock is up from $140 to over HokieHead 12/06/16 09:27:25 AM
#702   Good morning Folks! I'm surprise to be the corpus 12/06/16 09:21:33 AM
PostSubject